Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
HURA
HURA
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
HURA News
TuHURA Biosciences to Present at Oppenheimer Healthcare Conference
4d ago
PRnewswire
TuHURA Biosciences Receives Orphan Drug Designation for IFx-2.0
Feb 03 2026
stocktwits
TuHURA Biosciences Receives FDA Orphan Drug Designation
Feb 02 2026
Newsfilter
TuHURA Receives FDA Orphan Drug Designation
Feb 02 2026
PRnewswire
TuHURA Biosciences Releases 1.54M Shares to Kintara CVR Holders Following Clinical Trial Success
Dec 15 2025
PRnewswire
TuHURA Biosciences Advances Phase 3 Trial of IFx-2.0 for Merkel Cell Carcinoma
Dec 11 2025
PRnewswire
Post-Market Surge: Stoke Therapeutics, Alpha Tau Medical, and Compass Pathways Top Biotech Gainers
Dec 10 2025
NASDAQ.COM
TuHURA Biosciences Announces $1.65 Share Offering of 9.46 Million Shares
Dec 09 2025
PRnewswire
TuHURA Biosciences Issues 9.46M Shares at $1.65 Each in Direct Offering
Dec 09 2025
Newsfilter
Maxim Group Continues to Recommend Buy for TuHURA Biosciences (HURA)
Nov 15 2025
NASDAQ.COM
TuHURA Biosciences, Inc. Reports Third Quarter 2025 Financial Results and Provides a Corporate Update
Nov 14 2025
PRnewswire
TuHURA Biosciences Discovery Research on Targeting the Delta Opioid Receptor (DOR) to Reprogram Myeloid-Derived Suppressor Cells (MDSCs) Selected for Oral Presentation at the 67th ASH Annual Meeting and Exposition
Nov 03 2025
PRnewswire
TuHURA Biosciences, Inc. to Present at the 27th Annual H.C. Wainwright Global Investment Conference
Aug 20 2025
PRnewswire
TuHURA R&D Jumps 75% in Q2
Aug 15 2025
NASDAQ.COM
TuHURA Biosciences, Inc. Reports Second Quarter 2025 Financial Results and Provides a Corporate Update
Aug 14 2025
Newsfilter
TuHURA Biosciences, Inc. Announces Inclusion in the Russell 3000® and Russell 2000® Indexes
Jul 01 2025
Newsfilter
Show More News
